2448
K. Kraszewska et al. / Bioorg. Med. Chem. 19 (2011) 2443–2449
conformation, rarely found in the crystals of 20-deoxynucleosides,
resulting from a specific hydrogen bond network. By contrast, in
the RNA nucleoside series the conformational characteristics of
the ribofuranose ring are dramatically affected by desulfurization,
and the 4-pyrimidinone nucleoside 3 predominantly takes the
C20-endo form (S conformer) in aqueous solution. This ribose
pucker is also fixed for H2o4U molecules in the crystal state. The
observed difference between the s2U and H2o4U ribose folding
(71% of N conformer for s2U, 62% of S conformer for H2o4U) may
have important biological consequences as desulfurization of nat-
ural 2-thiouridines may occur under conditions of oxidative stress
in the cell.
Additionally, the absence of a 2-thiocarbonyl/2-carbonyl accep-
tor and a N3-H donor in the structure of H2o4U and dH2o4U may
play a significant role in modifying hydrogen bonding specificity
with regard to the pair with purine nucleosides. The development
of an efficient synthesis of modified nucleosides allows for the gen-
eration of phosphoramidites or nucleotide triphosphates, followed
by incorporation into oligonucleotides for further biophysical stud-
ies of modified sequences. It remains to be determined how these
modified nucleosides behave within the context of the oligonu-
cleotide. We are currently assessing the conformational impact of
H2o4U (3) and dH2o4U (4) within the context of model DNA and
RNA oligonucleotides.
4H, Ar), 7.56 (dd, 1H, J = 2.5 Hz, 7.9 Hz, H6), 7.91 (m, 4H, Ar), 8.61
(d, 1H, J = 2.5 Hz, H2).
4.1.3. General procedure for sugar deprotection
Compound 9 or 10 (2.9 mmol) was suspended in 0.1 M solution
of MeONa in MeOH. The mixture was stirred at room temperature
for 30 min. After this time TLC analysis (20% MeOH in CHCl3)
showed that the starting material was completely consumed. The
mixture was worked up with Dowex (pyridine salt form) and after
filtered off the resin, the remaining solution was evaporated in va-
cuo and coevaporated with toluene. The oily residue was dissolved
in water (15 ml) and washed with diethyl ether (3 ꢂ 10 ml). The
aqueous layer was frozen and lyophilized to give
respectively.
3
or 4,
4.1.3.1. 1-(b-
D
-Ribofuranosyl)-4-pyrimidinone (3).
Yield =
92%, TLC Rf: 0.23 (CH3Cl/CH3OH, 80:20), 0.42 (isopropanol/aq 25%
NH3/H2O, 7:1:2), 0.50 (n-butanol/ethanol/H2O, 40:11:19); 1H
NMR (D2O) d 3.75 (dd, 1H, J = 4.1 Hz, 12.7 Hz, H500), 3.82 (dd, 1H,
J = 3.2 Hz, 12.7 Hz, H50), 4.19 (ddd, 1H, J = 3.2 Hz, 3.5 Hz, 4.1 Hz,
H40), 4.24 (dd, 1H, J = 3.5 Hz, 5.4 Hz, H30), 4.32 (dd, 1H, J = 5.4 Hz,
5.7 Hz, H20), 5.58 (d, 1H, J = 5.7 Hz, H10), 6.43 (d, 1H, J = 7.7 Hz,
H5), 8.07 (dd, 1H, J = 2.6 Hz, 7.7 Hz, H6), 8.58 (d, 1H, J = 2.6 Hz,
13
H2); C NMR (D2O) d 60.9 (C50), 70.1 (C30), 75.0 (C40), 86.1 (C20),
94.8 (C10), 112.5 (C5), 140.7 (C6), 152.2 (C2), 173.8 (C4); FAB MS
m/z 229 [M+H]+; 227 [MꢀH]ꢀ; HRMS calculated for C9H13O5N2
([M+H]+) 229.0835, found m/z 229.0813; UV (H2O) kmax 243 nm;
4. Experimental
kmin 210 nm;
e .
= 7200 Mꢀ1cmꢀ1
4.1. Synthesis of modified nucleosides
4.1.3.2.
(4).
1-(b-
Yield = 91%, TLC Rf: 0.23 (CH3Cl/CH3OH, 80:20), 0.45 (iso-
D
-20-Deoxyribofuranosyl)-4-pyrimidinone
4.1.1. General methods
All reagents were commercially available. CH2Cl2 was predried
with K2CO3 and distilled from K2CO3/P2O5; pyridine was stirred
with NaOH, refluxed over ninhydrin for several hours, distilled
once from ninhydrin and once from CaH2; MeOH was distilled from
Mg; toluene was distilled from Na. Silica gel column chromatogra-
phy was performed using Merck silica gel 60 (230–400 mesh). TLC
was performed on analytical silica plates (Kieselgel 60 F254/0.2 mm
thickness). NMR spectra were obtained on Bruker Avance 250 1H
and 13C NMR chemical shifts are in ppm, and J values are in Hz.
Mass spectra were obtained on Finnigan MAT 95 spectrometer.
propanol/aq 25% NH3/H2O, 7:1:2); 1H NMR (D2O) d 2.44 (ddd, 1H,
J = 6.5 Hz, 6.8 Hz, 14.4 Hz, H20), 2.50 (ddd, 1H, J = 3.9 Hz, 6.4 Hz,
14.4 Hz, H200), 3.64 (dd, 1H, J = 4.9 Hz, 12.6, H500), 3.72 (dd, 1H,
J = 3.6 Hz, 12.6, H50), 4.00 (ddd, 1H, J = 3.6 Hz, 3.7 Hz, 4.9 Hz, H40),
4.40 (ddd, 1H, J = 3.7 Hz, 3.9 Hz, 6.5 Hz, H30), 5.93 (dd, 1H,
J = 6.4 Hz, 6.8 Hz, H10), 6.33 (d, 1H, J = 7.8 Hz, H5), 7.95 (dd, 1H,
J = 2.5 Hz, 7.8 Hz, H6), 8.49 (d, 1H, J = 2.5 Hz, H2), 13C NMR (D2O)
d 38.28 (C20), 59.22 (C50), 68.59 (C30), 85.77 (C40), 90.04 (C10),
110.45 (C5), 139.24 (C6), 150.49 (C2), 171.85 (C4); FAB MS m/z
213 [M+H]+; HRMS calculated for C9H13O4N2 ([M+H]+) 213.0834,
found
e
m/z
213.0815;
.
UV
(H2O)
kmax = 241 nm,
4.1.2. General procedure for oxidative desulfurization
= 16,200 Mꢀ1 cmꢀ1
Nucleoside 7 or 8 (3 mmol) was dissolved in the mixture of
anhydrous CH2Cl2 (25 mL) and anhydrous pyridine (5 ml) and then
0.2 M mCPBA in CH2Cl2 (30 ml) was added. The solution was stir-
red at room temperature and after 3 h reaction was judged to be
complete by TLC (2% MeOH in CHCl3). The mixture was washed
with 10% Na2SO3 (50 ml), 5% NaHCO3 (50 ml), dried over MgSO4
and evaporated. The crude product was coevaporated with toluene
(3 ꢂ 10 ml) and purified by silica gel column chromatography
(0–5% MeOH in CHCl3) to give 9 or 10, respectively.
4.2. X-ray structure analysis
Crystal data for dH2o4U (4): C9H12N2O4, M = 212.21, orthorom-
0
0
bic, space group P212121, a = 7.6490(2) ÅA, b = 8.1401(2) ÅA, c =
0
0
15.2382(4) ÅA, V = 948.79(4) ÅA3, Z = 4, Dx = 1.486 g cmꢀ3, T = 293 K,
0
l
= 0.118 mmꢀ1, k = 0.71073 ÅA, data/parameters = 1669/139; Flack
x = 0.0(9), final R1 = 0.0226.
Crystal data for H2o4U (3): C9H12N2O5, M = 228.21, orthorombic,
0
0
4.1.2.1. 20,30,50-Tri-O-benzoyl-1-(b-
none (9).
D
-ribofuranosyl)-4-pyrimidi-
space group P212121, a = 06.5028(2) ÅA, b = 9.4577(3) ÅA, c =
0
15.7834(4) ÅA, V = 970.70(5) ÅA3, Z = 4, Dx = 1.561 g cmꢀ3, T = 293 K,
Yield = 81%; TLC Rf: 0.26 (CH3Cl/CH3OH, 95:5);
0
0.23 (benzene/EtOAc, 7:3); 1H NMR (CDCl3) d 4.73 (dd, 1H,
J = 2.6 Hz, 12.0 Hz, H500), 4.84 (m, 1H, H40), 4.88 (dd, 1H,
J = 2.5 Hz, 12.0 Hz, H50), 5.67 (pt, 1H, J = 5.8 Hz, H30), 5.83 (m, 2H,
H20, H5), 6.13 (d, 1H, J = 7.9 Hz, H10), 7.36–7.68 (m, 10H, H6, Bz),
7.90–8.12 (m, 6H, Bz), 8.35 (d, 1H, J = 2.6 Hz, H2).
l
= 0.129 mmꢀ1, k = 0.71073 ÅA, data/parameters = 1726/147; Flack
x = 0.2(8), final R1 = 0.0221.
Crystal data for ds2U (2): C9H12N2O4 S, M = 244.28, triclinic,
0
0
0
space group P1, a = 10.377(3) ÅA, b = 11.784(3) ÅA, c = 13.434(4) ÅA,
0
a
= 100.2(1)°, b = 112.6(1)°,
c
= 103.9(1)°, V = 1403.4(7) ÅA30 , Z = 4,
Dx = 1.156 g cmꢀ3, T = 293 K,
l
= 0.231 mmꢀ1, k = 0.71073 ÅA, data/
4.1.2.2. 30,50-Di-O -toluyl-1-(b-
midinone (10).
D
-20-deoxyribofuranosyl)-4-pyri-
Yield = 83%; TLC Rf: 0.23 (CH3Cl/CH3OH,
parameters = 4410/580; Flack x = 0.3 (1), final R1 = 0.0631.
Crystals of H2o4U (3) and dH2o4U (4) as well as ds2U (2) were
obtained by slow evaporation from their aqueous methanolic solu-
tions. The measurements of the crystals were performed on a
SMART diffractometer with graphite-monochromated MoK
tion (k = 0.71073 ÅA) at room temperature. The structures were
95:5); 1H NMR (CDCl3) d 2.43 (d, 6H, J = 2.1 Hz, CH3), 2.50 (m,
1H, H200), 2.77 (ddd, 1H, J = 1.8 Hz, 5.5 Hz, 14.3 Hz, H20), 4.60 (m,
1H, H40), 4.71 (m, 2H, H50 and H500), 5.66 (m, 1H, H30), 5.95 (dd,
1H, J = 5.5 Hz, 8.5 Hz, H10), 6.14 (d, 1H, J = 7.9 Hz, H5), 7.27 (m,
a
radia-
0